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CDC HEALTH UPDATE
Update: Destruction of influenza A (H2N2) proficiency testing samples; 
interim guidance for Biosafety Level 3-enhanced biocontainment for work 
with human influenza A (H2N2) viruses
All influenza A (H2N2) samples that were prepared by a private contractor laboratory and distributed to 
laboratories and health care facilities in 18 countries as part of influenza proficiency testing panels have been 
accounted for and are reported by the proficiency testing organizations that sent out the panels as being 
destroyed. The organizations received written confirmations of destruction from their client laboratories that 
received these samples. The U.S. Department of Health and Human Services (HHS), the Centers for Disease 
Control and Prevention (CDC), and the World Health Organization (WHO) are continuing follow up investigations 
to evaluate the cause of the incident and determine how best to prevent similar incidents from occurring in the 
future.
As of May 3, 2005, there have been no confirmed reports of H2N2-related illness associated with possible 
exposure to the proficiency testing samples. CDC and other public health agencies will continue to follow up 
reports of possible cases of influenza-like illness among laboratory workers occurring after working with the 
samples that contained H2N2. See the Health Alert Network (HAN) notice of April 15 (available on the CDC 
website at http://www.cdc.gov/flu/h2n2situation.htm) for more information about these follow-up procedures. CDC 
and HHS are also in touch with foreign governments and WHO regarding investigations of any reports of possible 
H2N2-related influenza-like illness worldwide.
As reported in the HAN notices of April 13 and April 15, the influenza A (H2N2) samples were included in 
laboratory proficiency testing panels distributed to U.S. and international laboratories from October 2004 through 
March 2005. Following full characterization of the influenza A isolate submitted to Canadian public health 
authorities, investigators recognized the virus in the proficiency testing kits as an influenza A (H2N2) virus that 
closely resembled the viruses circulating in 1957 and 1958; influenza A (H2N2) is a virus that has not circulated 
among humans since 1968. Because of the potential public health risk associated with this virus, public health 
agencies, including WHO, HHS, and CDC, recommended immediate destruction of all the proficiency test 
samples to prevent reintroduction of the strain.
Certification of the destruction of the H2N2 samples contained in the proficiency testing kits effectively ends the 
immediate risk associated with the distribution of these kits, but it is only the first step of the public health 
response. CDC has formed a multi-agency task force that will conduct an extensive investigation into the 
circumstances that led to the H2N2 samples being included in the proficiency testing kits. It is expected that the 
findings of the task force will be used to help improve the proficiency testing system and prevent an occurrence of 
a similar event in the future.
Additionally, CDC is working with the National Institutes of Health (NIH) to raise the recommended Biosafety 
Level for laboratory work involving some human influenza A (H2N2) viruses. CDC and NIH recommend that wild­
type non-contemporary human influenza A (H2N2) strains should be handled by using Biosafety Level 3 and
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Animal Biosafety Level 3 practices, procedures, and facilities, with rigorous adherence to additional respiratory 
protection and clothing change protocols. Negative pressure, HEPA-filtered respirators or positive air-purifying 
respirators (PAPRs) are being recommended for use. Important considerations in working with these strains are 
the number of years since an antigenically related virus last circulated and the potential for presence of a 
susceptible population. For additional information about this interim laboratory guidance, please refer to CDC's 
website at http://www.cdc.gov/flu/h2n2bsl3.htm.
For additional information about the influenza A (H2N2) situation, please refer to CDC's website at
http://www.cdc.gov/flu/h2n2situation.htm.
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
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• Health Alert: Conveys the highest level of importance; warrants immediate action or attention. Example: 
HAN00001
• Health Advisory: Provides important information for a specific incident or situation; may not require 
immediate action. Example: HAN00316
• Health Update: Provides updated information regarding an incident or situation; unlikely to require 
immediate action. Example: HAN00309
• Info Service: Provides general information that is not necessarily considered to be of an emergent nature. 
Example: HAN00319
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